We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current BIOM3 market cap is 1.25B. The company's latest EPS is BRL -0.6397 and P/E is -15.35.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 33.13M | 20M | 38.56M | 32.08M | 32.26M |
| Operating Income | -19.9M | -18.73M | -17.54M | -20.52M | -18.89M |
| Net Income | -21.93M | -21.06M | -17.08M | -18.28M | -16.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Revenue | 8.94M | 58.67M | 107.09M | 104.95M | 118.19M |
| Operating Income | -52.61M | -55.57M | -65.65M | -86.24M | -72.53M |
| Net Income | -55.81M | -70.77M | -80.26M | -92.56M | -81.14M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 339.41M | 344.7M | 541.44M | 504.14M | 486.44M |
| Total Liabilities | 240.39M | 221.76M | 218.56M | 199.47M | 198.07M |
| Total Equity | 99.01M | 122.94M | 322.88M | 304.66M | 288.37M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Total Assets | 388.77M | 434.97M | 369.83M | 405.09M | 344.7M |
| Total Liabilities | 235.21M | 243.49M | 258.25M | 245.98M | 221.76M |
| Total Equity | 153.56M | 191.48M | 111.59M | 159.11M | 122.94M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | -57.31M | -74.79M | -43.25M | -66.5M | -81.15M |
| Investing | 1.35M | -2.86M | -79.81M | -77.7M | -72.78M |
| Financing | -222k | 25.56M | 215.9M | 194.79M | 187.57M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
| Operating | -80.85M | -96.87M | -93.78M | -63M | -74.79M |
| Investing | -20.52M | -6.84M | 61.49M | -6.16M | -2.86M |
| Financing | 110.65M | 130.85M | 7.42M | 113.79M | 25.56M |
| Market Cap | 1.25B |
| Price to Earnings Ratio | -15.35 |
| Price to Sales Ratio | 10.54 |
| Price to Cash Ratio | 47.9 |
| Price to Book Ratio | 10.13 |
| Dividend Yield | - |
| Shares Outstanding | 126.84M |
| Average Volume (1 week) | 69.27k |
| Average Volume (1 Month) | 83.08k |
| 52 Week Change | -5.12% |
| 52 Week High | 21.20 |
| 52 Week Low | 6.84 |
| Spread (Intraday) | 0.32 (3.16%) |
| Company Name | Biomm SA |
| Address |
praca carlos chagas n. 49, 8 andar belo horizonte, minas gerais 30170-020 |
| Website | https://www.biomm.com |
| Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
